Spyre Therapeutics, Inc. ($SYRE)
Filing Information
| Accession Number | 0001636282-26-000076 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 4, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
22,500
Total Value
$641,686.98
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Jun 1, 2026 | Exercise/Conversion | 7,500 | $14.50 | $108,750.00 | 105,494 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 1, 2026 | Sale | 1,801 | $69.75 | $125,619.75 | 103,693 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 1, 2026 | Sale | 2,599 | $70.77 | $183,931.23 | 101,094 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 1, 2026 | Sale | 3,100 | $72.06 | $223,386.00 | 97,994 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Jun 1, 2026 | Exercise/Conversion | 7,500 | $0.00 | $0.00 | 374,857 | Direct | โ | View Details |